MG
NVO

Michael Gelband’s Novo Nordisk NVO Stock Holding History

Michael Gelband’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.18M Buy
+170,652
New +$7.33M 0.05% 349
2026
Q1 		– Sell
-274,272
Closed -$14M – 1930
2025
Q4 		$14M Buy
+274,272
New +$14M 0.11% 169
2024
Q4 		– Sell
-115,785
Closed -$13.8M – 1891
2024
Q3 		$13.8M Buy
+115,785
New +$15.4M 0.08% 186
2023
Q3 		– Sell
-3,180
Closed -$257K – 2003
2023
Q2 		$257K Sell
3,180
-195,236
-98% -$15.9M ﹤0.01% 1601
2023
Q1 		$15.8M Buy
198,416
+58,696
+42% +$4.16M 0.13% 165
2022
Q4 		$9.46M Buy
139,720
+95,040
+213% +$5.57M 0.14% 186
2022
Q3 		$2.23M Sell
44,680
-303,472
-87% -$16.3M 0.03% 757
2022
Q2 		$19.4M Buy
348,152
+308,192
+771% +$17.1M 0.24% 74
2022
Q1 		$2.22M Buy
39,960
+23,074
+137% +$1.18M 0.03% 724
2021
Q4 		$946K Buy
+16,886
New +$915K 0.01% 1107
2021
Q2 		– Sell
-37,786
Closed -$1.27M – 2665
2021
Q1 		$1.27M Buy
37,786
+17,902
+90% +$638K 0.02% 781
2020
Q4 		$694K Buy
+19,884
New +$687K 0.01% 1053
2020
Q3 		– Sell
-13,906
Closed -$455K – 2087
2020
Q2 		$455K Buy
13,906
+6,242
+81% +$199K 0.01% 1129
2020
Q1 		$231K Buy
+7,664
New +$228K 0.01% 734
2019
Q3 		– Sell
-65,960
Closed -$1.68M – 1543
2019
Q2 		$1.68M Buy
+65,960
New +$1.63M 0.07% 178

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Michael Gelband's NVO Position: Q2 2026 in Review

Michael Gelband opened a new position in Novo Nordisk (NVO) in Q2 2026: 170,652 shares worth $8.18M. The stake represents 0.05% of the portfolio and ranks #349 among its holdings. This is a return to the name: Michael Gelband previously reported a position in NVO as recently as Q4 2025.

Michael Gelband first reported a position in NVO in Q2 2019 and has held it in 15 quarters since. The position peaked at $19.4M in Q2 2022. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Michael Gelband held 170,652 shares of Novo Nordisk worth $8.18M as of Q2 2026.
  • Novo Nordisk was a new Michael Gelband position in Q2 2026.
  • Novo Nordisk made up 0.05% of Michael Gelband's portfolio in Q2 2026, its #349 holding.
  • Michael Gelband first reported a position in Novo Nordisk in Q2 2019 and has held it in 15 quarters since.
  • Michael Gelband's Novo Nordisk position peaked at $19.4M in Q2 2022.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.